Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksUnilever Regulatory News (ULVR)

Share Price Information for Unilever (ULVR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 4,229.00
Bid: 4,230.00
Ask: 4,231.00
Change: 17.00 (0.40%)
Spread: 1.00 (0.024%)
Open: 4,225.00
High: 4,250.00
Low: 4,222.00
Prev. Close: 4,212.00
ULVR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Implementation of Proposed Amendments

26 Nov 2020 15:15

RNS Number : 6698G
Unilever PLC
26 November 2020
 

UNILEVER ANNOUNCES IMPLEMENTATION OF PROPOSED AMENDMENTS

 

London/Rotterdam, 26 November 2020

 

Capitalised terms used but not defined in this announcement have the same meaning given to them in the Consent Solicitation Memorandum prepared by Unilever PLC ("PLC") and Unilever N.V. ("NV") dated 26 June 2020.

 

Notice is hereby given to the holders of the outstanding securities listed in the table below (each a "Series" and together, the "Notes") that:

 

a) the NV Demerger Effective Date occurred on 26 November 2020 whereby Unilever Finance Netherlands B.V. ("New Bond Sub") was incorporated and the NV Notes became obligations of New Bond Sub;

 

b) the Implementation Conditions in respect of each Series have been satisfied; and

 

c) the Proposed Amendments in respect of each Series have been implemented including, without limitation, (i) the substitution of New Bond Sub in place of NV as the Issuer of the NV Notes and (ii) the release of NV's obligations as Guarantor in respect of the PLC Notes, in each case, with effect from 26 November 2020.

 

 

Issuer

Guarantor

ISIN

Description

DIP Notes

New Bond Sub

PLC, UNUS

XS1654191623

€500,000,000 0.000 per cent. Notes due July 2021

New Bond Sub

PLC, UNUS

XS1178970106

€750,000,000 0.500 per cent. Notes due February 2022

New Bond Sub

PLC, UNUS

XS1566100977

€600,000,000 0.375 per cent. Notes due February 2023

New Bond Sub

PLC, UNUS

XS1241577490

€500,000,000 1.000 per cent. Notes due June 2023

New Bond Sub

PLC, UNUS

XS1769090728

€500,000,000 0.500 per cent. Notes due August 2023

New Bond Sub

PLC, UNUS

XS1403014936

€500,000,000 0.500 per cent. Notes due April 2024

New Bond Sub

PLC, UNUS

XS2147133495

€1,000,000,000 1.250 per cent. Notes due March 2025

New Bond Sub

PLC, UNUS

XS1654192191

€650,000,000 0.875 per cent. Notes due July 2025

New Bond Sub

PLC, UNUS

XS1769090991

€700,000,000 1.125 per cent. Notes due February 2027

New Bond Sub

PLC, UNUS

XS1566101603

€600,000,000 1.000 per cent. Notes due February 2027

New Bond Sub

PLC, UNUS

XS1403015156

€700,000,000 1.125 per cent. Notes due April 2028

New Bond Sub

PLC, UNUS

XS1654192274

€750,000,000 1.375 per cent. Notes due July 2029

New Bond Sub

PLC, UNUS

XS2147133578

€1,000,000,000 1.750 per cent. Notes due March 2030

New Bond Sub

PLC, UNUS

XS1769091296

€800,000,000 1.625 per cent. Notes due February 2033

PLC

UNUS

XS1560644830

£350,000,000 1.125 per cent. Notes due February 2022

PLC

UNUS

XS1684780031

£250,000,000 1.375 per cent. Notes due September 2024

PLC

UNUS

XS2008921277

£500,000,000 1.500 per cent. Notes due July 2026

PLC

UNUS

XS1684780205

£250,000,000 1.875 per cent. Notes due September 2029

PLC

UNUS

XS2008925344

€650,000,000 1.500 per cent. Notes due June 2039

Standalone Notes

New Bond Sub

PLC, UNUS

XS1873208950

€650,000,000 0.500 per cent. Bonds due January 2025

New Bond Sub

PLC, UNUS

XS1873209172

€650,000,000 1.375 per cent. Bonds due September 2030

 

 

Supplemental Trust Deeds

 

The Supplemental Trust Deeds for each Issuer implementing the relevant Proposed Amendments in respect of all Series of Notes have been executed by, inter alia, the Trustee, the relevant Issuer and the relevant Guarantors.

 

This notice is given by:

 

Unilever Finance Netherlands B.V., Unilever N.V. and Unilever PLC

 

26 November 2020

 

 

DISCLAIMER

 

Safe Harbour

 

This announcement may contain forward-looking statements, including 'forward-looking statements' within the meaning of the United States Private Securities Litigation Reform Act of 1995. Words such as 'will', 'aim', 'expects', 'anticipates', 'intends', 'looks', 'believes', 'vision', or the negative of these terms and other similar expressions of future performance or results, and their negatives, are intended to identify such forward-looking statements. These forward-looking statements are based upon current expectations and assumptions regarding anticipated developments and other factors affecting the Unilever Group (the "Group" or "Unilever"). They are not historical facts, nor are they guarantees of future performance.

 

Because these forward-looking statements involve risks and uncertainties, there are important factors that could cause actual results to differ materially from those expressed or implied by these forward-looking statements. Among other risks and uncertainties, the material or principal factors which could cause actual results to differ materially are: Unilever's global brands not meeting consumer preferences; Unilever's ability to innovate and remain competitive; Unilever's investment choices in its portfolio management; the effect of climate change on Unilever's business; Unilever's ability to find sustainable solutions to its plastic packaging; significant changes or deterioration in customer relationships; the recruitment and retention of talented employees; disruptions in our supply chain and distribution; increases or volatility in the cost of raw materials and commodities; the production of safe and high quality products; secure and reliable IT infrastructure; execution of acquisitions, divestitures and business transformation projects; economic, social and political risks and natural disasters; financial risks; failure to meet high and ethical standards; and managing regulatory, tax and legal matters. A number of these risks have increased as a result of the current COVID-19 pandemic. These forward-looking statements speak only as of the date of this announcement. Except as required by any applicable law or regulation, the Group expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained herein to reflect any change in the Group's expectations with regard thereto or any change in events, conditions or circumstances on which any such statement is based. Further details of potential risks and uncertainties affecting the Group are described in the Group's filings with the London Stock Exchange, Euronext Amsterdam and the US Securities and Exchange Commission (the "SEC"), including in the Annual Report on Form 20-F 2019 and the Unilever Annual Report and Accounts 2019.

 

Important Information

This announcement is for informational purposes only and does not constitute or form part of an offer to sell or the solicitation of an offer to buy or subscribe to any securities, nor shall there be any sale of securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction. This announcement is not an offer of securities for sale into the United States. No offering of securities shall be made in the United States except pursuant to registration under the US Securities Act of 1933 (the "Securities Act"), or an exemption therefrom. In connection with Unification, Unilever PLC expects to issue ordinary shares (including ordinary shares represented by American Depositary Shares) to security holders of Unilever N.V. in reliance upon the exemption from the registration requirements of the Securities Act provided by Section 3(a)(10) thereof. Unification has not been and will not be approved or disapproved by the SEC, nor has the SEC or any US state securities commission passed upon the merits or fairness of Unification. Any representation to the contrary is a criminal offence in the United States.

 

The release, publication or distribution of this announcement in certain jurisdictions may be restricted by law and therefore persons in such jurisdictions into which this announcement is released, published or distributed should inform themselves about and observe such restrictions.

 

No solicitation will be made in any jurisdiction in which the making or acceptance thereof would not be in compliance with the laws of such jurisdiction.

 

This announcement does not constitute or form part of any offer or invitation to sell, or any solicitation of any offer to purchase. It is not an advertisement and not a prospectus for the purposes of Regulation (EU) 2017/1129.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCBFBITMTATBTM
Date   Source Headline
8th May 20244:00 pmRNSDirector/PDMR Shareholding
1st May 20244:10 pmRNSResult of AGM
1st May 20243:17 pmRNSCommittee Composition
1st May 20249:06 amRNSTotal Voting Rights
25th Apr 20247:00 amRNSQ1 2024 Trading Statement
2nd Apr 20243:58 pmRNSTotal Voting Rights
28th Mar 20245:04 pmRNSDirector/PDMR Shareholding
27th Mar 202412:32 pmRNSDirector/PDMR Shareholding
26th Mar 20246:13 pmRNSDirector/PDMR Shareholding
26th Mar 202411:58 amRNSDirector/PDMR Shareholding
25th Mar 20243:10 pmRNSDirector/PDMR Shareholding
19th Mar 20247:00 amRNSUnilever to accelerate Growth Action Plan
18th Mar 20243:00 pmRNSNotice of AGM
14th Mar 20242:14 pmRNSAnnual Financial Report
13th Mar 20247:00 amRNSBlock Listing of Shares
11th Mar 20245:55 pmRNSDirector/PDMR Shareholding
1st Mar 20242:36 pmRNSTotal Voting Rights
19th Feb 20243:14 pmRNSDirector/PDMR Shareholding
8th Feb 20247:00 amRNSFinal Results
1st Feb 20245:04 pmRNSTotal Voting Rights
31st Jan 20243:00 pmRNSDirectorate Change
16th Jan 20245:10 pmRNSBlock listing Interim Review
2nd Jan 20242:54 pmRNSTotal Voting Rights
27th Dec 20237:00 amRNSDirector/PDMR Shareholding
15th Dec 20235:48 pmRNSDirector/PDMR Shareholding
12th Dec 20235:51 pmRNSDirector/PDMR Shareholding
11th Dec 20235:48 pmRNSDirector/PDMR Shareholding
11th Dec 20235:43 pmRNSDirector/PDMR Shareholding
4th Dec 20235:28 pmRNSTotal Voting Rights
23rd Nov 20233:51 pmRNSDirector/PDMR Shareholding
22nd Nov 20235:44 pmRNSDirector/PDMR Shareholding
10th Nov 20235:33 pmRNSDirector/PDMR Shareholding
8th Nov 20236:05 pmRNSDirector/PDMR Shareholding
1st Nov 20233:36 pmRNSTotal Voting Rights
30th Oct 20234:33 pmRNSStatement re Director Remuneration Report AGM Vote
26th Oct 20237:01 amRNSUnilever Announces New CFO
26th Oct 20237:00 amRNS3rd Quarter Results
18th Oct 20232:00 pmRNSCompletion of the 4th Tranche Share Buyback
17th Oct 20235:57 pmRNSTransaction in Own Shares
16th Oct 20236:01 pmRNSTransaction in Own Shares
13th Oct 20235:58 pmRNSTransaction in Own Shares
12th Oct 20235:50 pmRNSTransaction in Own Shares
12th Oct 20239:04 amRNSChanges to Membership of Board Committees
11th Oct 20236:06 pmRNSTransaction in Own Shares
11th Oct 20234:37 pmRNSDirector/PDMR Shareholding
10th Oct 20235:42 pmRNSTransaction in Own Shares
9th Oct 20236:05 pmRNSTransaction in Own Shares
6th Oct 20235:55 pmRNSTransaction in Own Shares
5th Oct 20235:46 pmRNSTransaction in Own Shares
4th Oct 20235:54 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.